Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach

被引:14
作者
Doki, Y [1 ]
Ishikawa, O [1 ]
Kabuto, T [1 ]
Hiratsuka, M [1 ]
Sasaki, Y [1 ]
Ohigashi, H [1 ]
Kameyama, M [1 ]
Murata, K [1 ]
Yamada, T [1 ]
Miyashiro, I [1 ]
Yokoyama, S [1 ]
Imaoka, S [1 ]
机构
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, Osaka 5378511, Japan
关键词
D O I
10.1067/msy.2003.134
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The caudal spread of esophageal squamous cell carcinoma (ESCC) frequently involves the stomach. An extended surgical treatment may provide a tumor-free margin; however, its clinical benefit has not been elucidated. Methods. Sixty-three of 582 patients with ESCC (11 %) had massive gastric involvement and underwent esophagectomy with combined. resection of the stomach and other organs. The mode of gastric involvement was classified as direct invasion from primary tumor (PT invasion) or invasion from metastatic lymph nodes (LN invasion). Results. In addition to the removal of either the proximal (83 %) or the whole (17 %) stomach, 46 patients (73 %) underwent the combined resection of adjacent organs, including the diaphragm, pancreas, liver, lung, and pericardium. This surgical treatment resulted in a high rate (83 %) of curative resection and a low rate (8 %) of operative mortality. Postoperative survival rates were 53 %, 33 % and 25 % at 1, 2, and 5 years, respectively. The first tumor recurrence was frequently in the abdominal paraaortic lymph nodes (41 %) and the liver (28 %), followed by the mediastinal lymph nodes, local recurrence, the lung, and other organs. The mode of gastric involvement strongly affected clinical outcome, with a 5-year survival rate of 36 % for those with PT invasion but of only 7 % with LN invasion (P < .0086). No significant difference was seen in the number and location of metastatic lymph nodes between the 2 groups,- however, the size of the largest metastatic lymph node was significantly smaller with PT invasion than with LN invasion (12 mm vs 37 min in diameter; P < .0001). Conclusion. Surgical treatment of ESCC involving the stomach was considered safe and successful. A favorable prognosis can be expected for gastric invasion from the primary tumor but not from metastatic lymph nodes.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 26 条
[1]
RADICAL LYMPH-NODE DISSECTION FOR CANCER OF THE THORACIC ESOPHAGUS [J].
AKIYAMA, H ;
TSURUMARU, M ;
UDAGAWA, H ;
KAJIYAMA, Y .
ANNALS OF SURGERY, 1994, 220 (03) :364-373
[2]
ESOPHAGEAL-CARCINOMA WITH AIRWAY INVASION - EVOLUTION AND CHOICES OF THERAPY [J].
ALTORKI, NK ;
MIGLIORE, M ;
SKINNER, DB .
CHEST, 1994, 106 (03) :742-745
[3]
Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus [J].
Bhansali, MS ;
Fujita, H ;
Kakegawa, T ;
Yamana, H ;
Ono, T ;
Hikita, S ;
Toh, Y ;
Fujii, T ;
Tou, U ;
Shirouzu, K .
WORLD JOURNAL OF SURGERY, 1997, 21 (03) :275-281
[4]
Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers [J].
Doki, Y ;
Ishikawa, O ;
Mano, M ;
Hiratsuka, M ;
Sasaki, Y ;
Kameyama, M ;
Ohigashi, H ;
Murata, K ;
Yamada, T ;
Miyashiro, I ;
Yokoyama, S ;
Ishiguro, S ;
Imaoka, S .
JOURNAL OF SURGICAL RESEARCH, 2002, 107 (01) :75-81
[5]
Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer? [J].
Doki, Y ;
Kabuto, T ;
Ishikawa, O ;
Ohigashi, H ;
Sasaki, Y ;
Yamada, T ;
Hiratsuka, M ;
Miyashiro, I ;
Kameyama, M ;
Murata, K ;
Imaoka, S ;
Yasuda, T ;
Nakaizumi, A ;
Takenaka, A .
SURGERY, 2001, 130 (05) :792-797
[6]
Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy [J].
Dresner, SM ;
Griffin, SM .
BRITISH JOURNAL OF SURGERY, 2000, 87 (10) :1426-1433
[7]
Ichiyoshi Y, 1999, Jpn J Thorac Cardiovasc Surg, V47, P318
[8]
Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: Nine Japanese institutions trial [J].
Ishida, K ;
Iizuka, T ;
Ando, N ;
Ide, H .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (05) :310-315
[9]
Barrett's metaplasia [J].
Jankowski, JA ;
Harrison, RF ;
Perry, I ;
Balkwill, F ;
Tselepis, C .
LANCET, 2000, 356 (9247) :2079-2085
[10]
*JAP SOC ES DIS, 2001, COMPR REG ES CANC JA